Kgm Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
About Kgm Biotech
Kgm Biotech Limited (KBL) is a Public Limited Indian Non-Government Company incorporated in India on 18 August 2004 and has a history of 20 years and five months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kasani Gnaneshwar, Chandrakala Kasani, and Veeresh Kasani serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U01122TG2004PLC043932
- Company No.
043932
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2004
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Kgm Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kasani Gnaneshwar  | Director | 18-Aug-2004 | Current |
| Chandrakala Kasani | Director | 10-Apr-2019 | Current |
| Veeresh Kasani | Director | 20-Apr-2019 | Current |
Financial Performance of Kgm Biotech.
Kgm Biotech Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kgm Biotech?
In 2017, Kgm Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Akshainne Health Care Private LimitedKasani Gnaneshwar and Veeresh Kasani are mutual person
- Dhakshin Wellness And Ayurveda Private Limited
Kasani Gnaneshwar is a mutual person
- Kasani Constructions Private Limited
Kasani Gnaneshwar and Veeresh Kasani are mutual person
- Impressive Hotels And Resorts Private Limited
Kasani Gnaneshwar and Chandrakala Kasani are mutual person
- Kasani Hotels And Resorts Private Limited
Kasani Gnaneshwar and Chandrakala Kasani are mutual person
- Winningedge Communications Limited
Kasani Gnaneshwar and Veeresh Kasani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kgm Biotech?
Unlock and access historical data on people associated with Kgm Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kgm Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kgm Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.